Compare alternative providers
Alternatives to Ivy Rx
Ivy Rx grades C (66.8/100), #200 of 541 on our scorecard. Start with a featured alternative, then explore providers with similar listed prices and treatment options. Compare their scores and terms below.
You're comparing against
Ivy Rx →Featured alternative
CoreAge Rx scores 89.5/100. Check the price conditions and care terms against Ivy Rx.
Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
More options to compare
Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
Rx.com advertises bundled GLP-1 care, medication and supplies, with confirmation before refills and a named dispensing pharmacy.
Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.
HealthRX publishes $99 introductory injections with separate recurring and prepaid totals. At current prices, six monthly tirzepatide payments match the six-month prepaid subscription; semaglutide offers a prepaid saving.
An established pharmacy operator with steady mid-market pricing and a broad catalog.
The 6 alternatives above offer other options to compare with Ivy Rx. Every provider we grade — all 541 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.